iSpecimen annual free cash flow
2020
2021
2022
2023
2024
2025
iSpecimen Free Cash Flow (FCF) History (ISPC)
iSpecimen reported −$4.2M in free cash flow for fiscal 2025, an increase of $4.1M from the previous fiscal year, with a free cash flow margin of −219.86%.
View full iSpecimen company overviewiSpecimen free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$4.2M | $4.1M | — | −219.86% |
| 2024 | 2024-12-31 | −$8.3M | −$2.5M | — | −89.28% |
| 2023 | 2023-12-31 | −$5.8M | $206,196 | — | −58.69% |
| 2022 | 2022-12-31 | −$6.0M | $4.6M | — | −58.00% |
| 2021 | 2021-12-31 | −$10.7M | −$10.4M | — | −95.83% |
| 2020 | 2020-12-31 | −$288,806 | — | — | −3.53% |
iSpecimen quarterly free cash flow
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q3.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$689,625 | $404,338 | — | −453.88% |
| Q1 2026 | 2026-03-31 | −$4.1M | −$2.5M | — | −2603.60% |
| Q3 2025 | 2025-09-30 | −$2.0M | $45,893 | — | −1909.72% |
| Q4 2024 | 2024-12-31 | −$3.6M | −$3.9M | — | −242.67% |
| Q3 2024 | 2024-09-30 | −$1.1M | $545,543 | — | −41.10% |
| Q2 2024 | 2024-06-30 | −$1.5M | $159,805 | — | −53.75% |
| Q1 2024 | 2024-03-31 | −$2.1M | $752,108 | — | −90.90% |
| Q4 2023 | 2023-12-31 | $345,141 | $1.9M | — | +13.40% |
| Q3 2023 | 2023-09-30 | −$1.6M | $1.4M | — | −59.02% |
| Q2 2023 | 2023-06-30 | −$1.7M | $717,024 | — | −104.55% |
| Q1 2023 | 2023-03-31 | −$2.8M | −$1.1M | — | −96.05% |
| Q4 2022 | 2022-12-31 | −$1.5M | $216,359 | — | −52.04% |
| Q3 2022 | 2022-09-30 | −$3.0M | $3.1M | — | −117.23% |
| Q2 2022 | 2022-06-30 | −$2.4M | $952,003 | — | −103.31% |
| Q1 2022 | 2022-03-31 | −$1.7M | −$1.4M | — | −68.09% |
| Q4 2021 | 2021-12-31 | −$1.8M | −$1.4M | — | −68.95% |
| Q3 2021 | 2021-09-30 | −$6.1M | — | — | −223.66% |
| Q2 2021 | 2021-06-30 | −$3.4M | — | — | −115.99% |
| Q1 2021 | 2021-03-31 | −$340,783 | — | — | −11.50% |
| Q3 2020 | 2020-09-30 | −$319,410 | — | — | −14.20% |
iSpecimen free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$288,806 to −$4.2M, a net decrease of $4.0M. iSpecimen's latest reported quarter, Q2 2026, generated −$689,625 in free cash flow, an increase of $404,338 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review iSpecimen filings at SEC.gov ↗